Mammoth Biosciences News and Activities
Presence
Mammoth Biosciences develops CRISPR-based biotechnology products for gene editing, disease testing, and therapeutic research. Its tools and services support pharmaceutical companies, healthcare partners, and research organizations.
Mammoth Biosciences products and services overview:
- Gene editing tools
- Diagnostic tests
- Therapeutic research
- Molecular diagnostics
- Research services
Revenue: ~$20 million
Employees: 200
Headquarters: Brisbane, United States (USA)
Mammoth Biosciences is one of the...
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Mammoth Biosciences
Create your alert
to follow the executive moves at Mammoth Biosciences.
Biotechnology
Mammoth Biosciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Mammoth Biosciences
- Terms of Use - Mammoth Biosciences
- Privacy Policy - Mammoth Biosciences
- Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
- Mammoth Biosciences Announces Appointment of Phil Tinmouth, Siang Chin to Key Leadership Roles
- Mammoth Biosciences Named in BioSpace’s 2023 Best Places to Work
- Mammoth Biosciences Named to Fast Company’s 2022 List of the Next Big Things in Tech
- Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022
- Mammoth Biosciences Announces Key Leadership Appointments
- View more press releases Close
Social media about Mammoth Biosciences
- Mammoth Biosciences on Wikipedia, Google News & Yahoo Finance
- Mammoth Biosciences on LinkedIn, X (Twitter) & YouTube
